Average Co-Inventor Count = 2.81
ph-index = 4
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Vasopharm Gmbh (10 from 10 patents)
2. Janssen Pharmaceutica Nv (1 from 2,078 patents)
3. Vasopharm Biotech Gmbh (1 from 4 patents)
12 patents:
1. 12458644 - Process for preparing solutions comprising biopterin derivatives
2. 11717522 - Solid pharmaceutical compositions comprising biopterin derivatives and uses of such compositions
3. 10925877 - Solid pharmaceutical compositions comprising biopterin derivatives and uses of such compositions
4. 10493075 - Solid pharmaceutical compositions comprising biopterin derivatives and uses of such compositions
5. 10016431 - Solid pharmaceutical compositions comprising biopterin derivatives and uses of suchcompositions
6. 9895372 - Solid pharmaceutical compositions comprising biopterin derivatives and uses of such compositions
7. 9422289 - Use of pteridine derivatives for the treatment of increased intracranial pressure, secondary ischemia, and disorders associated with an increased level of cytotoxic reactive oxygen species
8. 9382252 - Use of pteridine derivatives for the treatment of increased intracranial pressure, secondary ischemia, and disorders associated with an increased level of cytotoxic reactive oxygen species
9. 8236809 - Substituted 1,2,3-triazolopyrimidines for the inhibition of NAD(P)H oxidases and platelet activation
10. 8222238 - Use of pteridine derivatives for the treatment of increased intracranial pressure, secondary ischemia, and disorders associated with an increased level of cytotoxic reactive oxygen species
11. 7732437 - Use of anti-histaminics for acute reduction of elevated intracranial pressure
12. 7541360 - 4-amino-7,8-dihydropteridines, pharmaceutical compositions containing them and their use for the treatment of diseases which are caused by an increased nitric oxide level